Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:31 PM
Ignite Modification Date:
2025-12-24 @ 10:31 PM
NCT ID:
NCT02792335
Eligibility Criteria:
Inclusion Criteria:
* Individuals with NVAF who were on warfarin and have switched to the NOACs (dabigatran, rivaroxaban and apixaban) within the study period January 01, 2013 through March 31, 2014
* Individuals ≥18 years old on the index date
* At least 1 year of baseline period with history of continuous warfarin use in the baseline period for at least 3 months immediately before the index date
* At least 1 diagnosis of AF in the 12 months prior to index date
* Continuous eligibility with medical and pharmacy benefits for at least 12 months before the index date through 1 month after the index date
Exclusion Criteria:
* Individuals with a diagnosis of valvular heart disease or cardiac surgery during the 12 months prior to index date
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02792335
Study Brief:
Protocol Section:
NCT02792335